Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
Peter Jenner, Huw R. Morris, Trevor W. Robbins, et al.
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 1, pp. 1-11
Open Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Alberto Calderone, Matteo Formenti, Federica Aprea, et al.
BMC Systems Biology (2016) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies
Catherine Labbé, Kotaro Ogaki, Oswaldo Lorenzo‐Betancor, et al.
Neurology (2015) Vol. 85, Iss. 19, pp. 1680-1686
Open Access | Times Cited: 34
Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases
Ruth Hornedo‐Ortega, Ana B. Cerezo, Ana M. Troncoso, et al.
Frontiers in Microbiology (2016) Vol. 6
Open Access | Times Cited: 29
Effect of Vasicinone against Paraquat-Induced MAPK/p53-Mediated Apoptosis via the IGF-1R/PI3K/AKT Pathway in a Parkinson’s Disease-Associated SH-SY5Y Cell Model
Da‐Tong Ju, Kalaiselvi Sivalingam, Wei‐Wen Kuo, et al.
Nutrients (2019) Vol. 11, Iss. 7, pp. 1655-1655
Open Access | Times Cited: 28
The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases
Grażyna Söderbom, Bai‐Yun Zeng
International review of neurobiology (2020), pp. 345-391
Closed Access | Times Cited: 24
Alpha-Synuclein and Cognitive Decline in Parkinson Disease
Tian-Sin Fan, Sam Chi-Hao Liu, Ruey‐Meei Wu
Life (2021) Vol. 11, Iss. 11, pp. 1239-1239
Open Access | Times Cited: 21
2-Aminopyrimidines as dual adenosine A1/A2A antagonists
Sarel J. Robinson, Jacobus P. Petzer, Gisella Terre’Blanche, et al.
European Journal of Medicinal Chemistry (2015) Vol. 104, pp. 177-188
Closed Access | Times Cited: 27
Mutations in the Parkinson’s Disease-Associated PARK2 Gene Are Accompanied by Imbalance in Programmed Cell Death Systems
Е. В. Коновалова, O. M. Lopacheva, И. А. Гривенников, et al.
Acta Naturae (2015) Vol. 7, Iss. 4, pp. 146-149
Open Access | Times Cited: 23
Impure Conceptual Analysis
Hans‐Johann Glock
Cambridge University Press eBooks (2017), pp. 77-100
Closed Access | Times Cited: 23
Clinicopathological Heterogeneity of Lewy Body Diseases: The Profound Influence of Comorbid Alzheimer Disease
Thomas G Beach, Geidy E. Serrano, Nan Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
A natural compound macelignan protects midbrain dopaminergic neurons from inflammatory degeneration via microglial arginase-1 expression
Kana Kiyofuji, Yuki Kurauchi, Akinori Hisatsune, et al.
European Journal of Pharmacology (2015) Vol. 760, pp. 129-135
Closed Access | Times Cited: 20
α‐synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease
Fatemeh Hadi, Hassan Akrami, Mehdi Totonchi, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 3, pp. 727-751
Open Access | Times Cited: 17
Does HIV Infection Alter Parkinson Disease?
Antoine Moulignier, Antoine Guéguen, François-Xavier Lescure, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2015) Vol. 70, Iss. 2, pp. 129-136
Open Access | Times Cited: 17
Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model
Alexandre Nay Rcom-H'cheo-Gauthier, Amelia Davis, Adrian Cuda Banda Meedeniya, et al.
Molecular and Cellular Neuroscience (2016) Vol. 77, pp. 65-75
Closed Access | Times Cited: 17
Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism
Fleur Alice McLeary, Alexandre Nay Rcom-H'cheo-Gauthier, Jessica Kinder, et al.
Neurotoxicity Research (2017) Vol. 33, Iss. 2, pp. 229-238
Closed Access | Times Cited: 16
Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling
Shasha Chen, Feng Cai, Jirong Wang, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 13
Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line
Felwah S. Al-Zaid, Michael J. Hurley, David T. Dexter, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Association between dipeptidyl peptidase-4 inhibitor use and risk of Parkinson’s disease among patients with diabetes mellitus: a retrospective cohort study
Kuang‐Hua Huang, Yih Yang, Shuo‐Yan Gau, et al.
Aging (2024) Vol. 16, Iss. 16, pp. 11994-12007
Open Access | Times Cited: 1
Armchair Metaphysics Revisited
Frank Jackson
Cambridge University Press eBooks (2017), pp. 122-140
Closed Access | Times Cited: 12
Disagreement in Philosophy
Herman Cappelen
Cambridge University Press eBooks (2017), pp. 56-75
Open Access | Times Cited: 12
Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
Akio Sekigawa, Yoshiki Takamatsu, Kazunari Sekiyama, et al.
Biomolecules (2015) Vol. 5, Iss. 2, pp. 1000-1011
Open Access | Times Cited: 11
On Metaphysical Quietism and Everyday Life
David Macarthur
Cambridge University Press eBooks (2017), pp. 249-273
Closed Access | Times Cited: 9
Serum metabolomics analysis revealed metabolic disorders in Parkinson’s disease
Tian-Tian Lan, Leslie Chang, Liwei Hou, et al.
Medicine (2023) Vol. 102, Iss. 23, pp. e33715-e33715
Open Access | Times Cited: 3
What is Negative Experimental Philosophy Good For?
Jonathan M. Weinberg
Cambridge University Press eBooks (2017), pp. 161-184
Closed Access | Times Cited: 8
Status and future directions of clinical trials in Parkinson's disease
Grażyna Söderbom
International review of neurobiology (2020), pp. 153-188
Closed Access | Times Cited: 8

Scroll to top